UC Irvine Electronic Theses and Dissertations
Total Page：16
File Type：pdf, Size：1020Kb
UC Irvine UC Irvine Electronic Theses and Dissertations Title Contribution of C5aR1 to Neuroinflammation and Neuronal Dysfunction in Alzheimer’s Disease Permalink https://escholarship.org/uc/item/7s66m6tf Author Hernandez, Michael Publication Date 2017 Peer reviewed|Thesis/dissertation eScholarship.org Powered by the California Digital Library University of California UNIVERSITY OF CALIFORNIA, IRVINE Contribution of C5aR1 to Neuroinflammation and Neuronal Dysfunction in Alzheimer’s Disease DISSERTATION submitted in partial satisfaCtion of the requirements for the degree of DOCTOR OF PHILOSOPHY in BiomediCal Sciences by MiChael Hernandez Dissertation Committee: Professor Andrea J. Tenner, Chair Professor Edwin S. Monuki AssoCiate Professor Kim Green 2017 © 2017 MiChael Hernandez DEDICATION To My sister, Jennifer, who has been there for me the entire way, and my friends, old and new. Thank you for your support and the many adventures we’ve shared. ii TABLE OF CONTENTS Page LIST OF FIGURES iv LIST OF TABLES viii ACKNOWLEDGMENTS x CURRICULUM VITAE xi ABSTRACT OF THE DISSERTATION xv CHAPTER 1: IntroduCtion 1 CHAPTER 2: C5a Increases the Injury to Primary Neurons EliCited by 20 Fibrillar Amyloid Beta CHAPTER 3: Prevention of C5aR1 Signaling Delays Microglial 47 Inflammatory Polarization, Favors Clearance Pathways and Suppresses Cognitive Loss CHAPTER 4: Comparing SurfaCe Expression of Proteins on MiCroglia 130 in vitro vs in vivo and MiCroglial Changes in AD CHAPTER 5: Summary and Future DireCtions 172 iii LIST OF FIGURES Page Figure 1.1. SChematiC diagram of Complement aCtivation by 6 fibrillar β-amyloid. Figure 1.2. C5aR1 inhibition maintains benefiCial response of 14 Complement aCtivation and inhibits detrimental response. Figure 2.1. CirCular diChroism of amyloid beta preparation Confirms 26 beta sheet structure. Figure 2.2. C5a at a ConCentration of 100 nM inCreases MAP-2 loss in 28 the presenCe of fAβ. Figure 2.3. C5aR1 expression on primary neurons. 32 Figure 2.4. C5a Causes MAP-2 loss in a dose-dependent manner. 34 Figure 2.5. C5a increases toxicity in fAβ-treated neurons. 35 Figure 2.6. Primary neuronal Cultures inClude GABAergiC and 37 glutamatergiC neurons. iv Figure 2.7. fAβ and C5a kill both GABAergiC and glutamatergiC neurons 38 in culture. Figure 3.1. Representative habituation performanCe during testing and 53 performanCe during training. Figure 3.2. PerformanCe in novel objeCt and objeCt location memory 62 tasks. Figure 3.3. Fibrillar plaque and CD45 miCroglial expression in 64 hippocampus. Figure 3.4. Aβ plaque load and CD45 expression in ArCtiC heterozygous 66 for CX3CR1 and CCR2. Figure 3.5. Glia clustering around plaques are CX3CR1+CCR2-. 69 Figure 3.6. Temporal gene expression profiles aCross four genotypes. 71 Figure 3.7. DynamiC gene expression profiles of remaining 7 Clusters. 73 Figure 3.8. Gene expression profiles of seleCted genes in inflammation 75 pathways. v Figure 3.9. Gene expression profiles of seleCted genes in lysosome and 78 phagosome pathways. Figure 3.10. Proposed meChanism by whiCh C5aR1 stimulation Contributes 84 to AD progression. Figure 4.1. CR1, CD200R, and TREM2 cell surface expression in M0, M1, 138 and M2a-polarized BV2 and primary neonatal miCroglia. Figure 4.2. Surface expression of CR1, CD200R, and TREM2 on miCroglia 139 isolated from adult miCe. Figure 4.3. Quality Control of 24 samples assayed. 142 Figure 4.4. Differentially expressed genes identified in the immunology 144 panel. Figure 4.5. Interferon signaling pathway. 146 Figure 4.6. Differentially expressed genes identified in the custom 155 neurodegeneration panel. vi Figure 4.7. Differentially expressed genes shared between immunology 160 and neurodegeneration Nanostring panels. Figure 5.1. PMX53 does not rescue fAb-induCed MAP-2 loss. 181 vii LIST OF TABLES Page Table 3.1. RNA quality Control. 88 Table 3.2. Gene ontology enriChment analysis. 89 Table 3.3. Pathway analysis. 95 Table 3.4. Genes found in eaCh maSigPro Cluster. 102 Table 4.1. Canonical pathways predicted to be activated or inhibited 149 in the ArCtiC brain relative to WT from immunology panel. Table 4.2. Diseases and funCtions enriChed in the ArCtiC brain relative 150 to WT from immunology panel. Table 4.3. Canonical pathways predicted to be activated or inhibited 153 in the ArCtiC C5aR1KO brain relative to ArCtiC from immunology panel. Table 4.4. Diseases and funCtions enriChed in the ArCtiC C5aR1KO 154 relative to ArCtiC from immunology panel. Table 4.5. Genes in Neurodegeneration Nanostring panel. 156 viii Table 4.6. Canonical pathways predicted to be activated or inhibited 157 in the ArCtiC brain relative to WT from neurodegeneration panel. Table 4.7. Diseases and funCtions enriChed in the ArCtiC relative to 158 WT from neurodegeneration panel. ix ACKNOWLEDGMENTS I would like to express the deepest appreCiation to my Committee Chair, Dr. Andrea Tenner, who has guided and enCouraged me throughout my graduate work. When things weren’t going well, and I wanted to Call it quits, she believed in me and enCouraged me to power through the tough times and appreCiate all the viCtories, both big and small. Thank you to all the Tenner lab members, both Current and past. They have truly made Coming to lab suCh an enjoyable experienCe. SpeCial thanks to Dr. Marisa FonseCa, Dr. Elizabeth Clarke, and Sophie Chu who were always there to offer help. Thank you to my undergraduates: Naomi, Karina, Anaïs, Pouya, and Eric – they helped make this possible. I would like to thank my Committee members, Dr. Edwin Monuki and Dr. Kim Green, their adviCe sinCe advanCing was instrumental to move my projeCts along. Thank you, Dr. Ali Mortazavi and Mandy Jiang, for the wonderful collaboration. I would also like to thank Dr. Lodoen and Dr. Nelson, and their respeCtive lab members, for the great feedback at each joint lab meeting. I’d like to espeCially thank Dr. Lanny Gov for being the best colleague I could ever hope for. Our walks to coffee and lunch dates offered muCh needed respite. In addition, thank you to Dr. Luis Mota-Bravo, Dr. Marlene de la Cruz; they enCouraged me to get involved in researCh when I was an undergraduate and have been my biggest cheerleaders ever since. Thank you to all the staff at MB&B and Pathology. Special thanks to Stefani Ching for being amazing and so very helpful. Thank you, Bessy Varela and Morgan Oldham for keeping my payCheCks Coming despite the Chaos of being involved with three departments. Finally, I would like to thank my friends and family. Thank you, Jennifer, for all your support. Couldn’t have asked for a more Caring and loving sister. Thank you, Snellings family, for so muCh that I Can’t even begin to list. Thank you, NiCk and Jason, for your friendship and many adventures we have shared, and for introduCing me to tons of new friends. Thank you, Brandon Bennett, for being the best gym husband at 5 A.M; I don’t think I Could have stayed sane without our morning workouts. Thank you, Lesly for your friendship since undergrad. Lastly, thank you to an amazing man, Jason Estep, who has made these last six months very speCial. The studies presented in this dissertation were supported by NIH grants NS 35144, AG00538, TG GM055246, T32 AG000096, and The Alzheimer’s AssoCiation. x CURRICULUM VITAE Michael Hernandez Professional Address: 2419 McGaugh Hall Department of MoleCular Biology & BioChemistry University of California, Irvine, 92697-3900 Email: [email protected] Telephone: 949-824-3266 Education: 2010-2017 Ph.D. BiomediCal SCienCes, Department of Pathology and Laboratory MediCine, University of California, Irvine 2005-2010: B.S. Biological Sciences, University of California, Irvine Honors and Awards: 2011-2014: NIH ResearCh Supplement to Promote Diversity in Health-Related Research 2014-2016: NIH Neurobiology of Aging Training Grant T32 -AG000096 2014: Travel Award from UCI SChool of MediCine 2015: Travel Award from UCI SChool of MediCine 2016: NIH UC Irvine Initiative for Maximizing Student Development (IMSD) Training Grant GM055246 2016: Travel Award from International Complement SoCiety 2017: Invited speaker for REMIND Emerging SCientists Symposium Teaching Experience: Fall, 2011: TeaChing Assistant: Neurobiology lab, N113L Winter 2016: TeaChing Assistant: BioChemistry, Bio SCi 98 TeaChing Assistant: Immunology, M121 Publications: Benoit M.E., Hernandez M.X., Dinh M.L., Benavente F., Vasquez O., Tenner A.J. 2013 C1q induced LRP1B and GPR6 Proteins Expressed Early in Alzheimer Disease Mouse Models, Are Essential for the C1q-mediated ProteCtion against Amyloid-beta NeurotoxiCity. J Biol Chem 288:654-665 RiCe R.A., Spangenberg E.E., Yamate-Morgan H., Lee R.J., Arora R.P., Hernandez M.X., Tenner A.J., West B.L., Green K.N. 2015 Elimination of MiCroglia Improves FunCtional OutComes Following Extensive Neuronal Loss in the HippoCampus. J Neurosci 35:9977- 9989 xi Hernandez M.X., Namiranian P., Nguyen E., FonseCa M.I., and Tenner A.J. 2017 C5a Increases the Injury to Primary Neurons EliCited by Fibrillar Amyloid Beta. ASN Neuro 9:1759091416687871 Fonseca, M.I., Chu, S., Hernandez, M.X., Fang, M.J., Modarresi, L., Selvan, P., MacGregor G.R. and Tenner, A.J., 2017 Cell speCifiC deletion of C1qa identifies miCroglia as the dominant sourCe of C1q in mouse brain. J Neuroinflammation 14:48 Hernandez M.X., Jiang S., Cole T.A., Chu S., FonseCa M.I., Wetsel R.A., Mortazavi A., and Tenner A.J. 2017 Prevention of C5aR1 Signaling on MiCroglia Favors ClearanCe Pathways, Delays Inflammatory Polarization and Suppresses Cognitive Loss. Manuscript submitted Alhoshani, A., Vu, V, V., Hernandez, M.X., Namiranian, P., Oakes, M., Tenner, A.J., Luptak, A., Cocco, M.J. 2017 DNA Aptamers that Bind Nogo-66 Promote Neuronal Outgrowth. Manuscript in preparation Abstracts and Meeting Presentations: Hernandez M., Ochoa-de la Paz L., Martinez-Torres A. Electrophysiological characterization of a current in Xenopus tropicalis oocytes.